XPF protein levels determine sensitivity of malignant melanoma cells to oxaliplatin chemotherapy: suitability as a biomarker for patient selection. (International journal of cancer. Journal international du cancer, 2014)

(untitled) - Hatch, S; Swift, L; Caporali, S; Carter, R; Hill, E; MacGregor, T; D'Atri, S; Middleton, MR; McHugh, P; Sharma, R